Cerevel Therapeutics Hldng I shares owned by Deutsche Bank Aktiengesellschaft
Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Deutsche Bank Aktiengesellschaft
from 13F filings
Historical chart of Deutsche Bank Aktiengesellschaft investment in Cerevel Therapeutics Hldng I
Tip: Access up to 7 years of quarterly data
All positions including Cerevel Therapeutics Hldng I held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cerevel Therapeutics Hldng I by Deutsche Bank Aktiengesellschaft
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $15M | 362k | 42.40 |
| 2023-09-30 | $741k | 34k | 21.83 |
| 2023-06-30 | $932k | 29k | 31.79 |
| 2023-03-31 | $1.0M | 41k | 24.39 |
| 2022-12-31 | $940k | 30k | 31.54 |
| 2022-09-30 | $705k | 25k | 28.32 |
| 2022-06-30 | $847k | 32k | 26.32 |
| 2022-03-31 | $924k | 26k | 35.03 |
| 2021-12-31 | $918k | 28k | 32.39 |
| 2021-09-30 | $787k | 27k | 29.74 |
| 2021-06-30 | $579k | 22k | 25.78 |
More positions owned by Deutsche Bank Aktiengesellschaft
View all positions for Deutsche Bank Aktiengesellschaft